Go back to the Europarl portal

Choisissez la langue de votre document :

  • bg - български
  • es - español
  • cs - čeština
  • da - dansk
  • de - Deutsch
  • et - eesti keel
  • el - ελληνικά
  • en - English (Selected)
  • fr - français
  • ga - Gaeilge
  • hr - hrvatski
  • it - italiano
  • lv - latviešu valoda
  • lt - lietuvių kalba
  • hu - magyar
  • mt - Malti
  • nl - Nederlands
  • pl - polski
  • pt - português
  • ro - română
  • sk - slovenčina
  • sl - slovenščina
  • fi - suomi
  • sv - svenska
Parliamentary questions
PDF 102kWORD 18k
15 October 2018
E-005281-18
Question for written answer E-005281-18
to the Commission
Rule 130
Thomas Waitz (Verts/ALE) , Maria Heubuch (Verts/ALE) , Bart Staes (Verts/ALE) , Marco Affronte (Verts/ALE) , Martin Häusling (Verts/ALE) , José Bové (Verts/ALE)

 Subject:  Implementation of the obligations laid down in Directive 2001/18/EC and Regulation (EC) No 1829/2003 on non-exempt mutagenesis-related techniques
 Answer in writing 

The Court of Justice’s judgment (Grand Chamber) of 25 July 2018 in Case C-528/16, disputed between the Confédération paysanne and others and the French prime minister and minister for agriculture, the food processing industry and forestry, concluded that all products obtained from mutagenesis-related techniques are to be considered GMOs under EC law, and that only techniques with a long history of safe use should be exempt.

Consequently, all mutagenesis-related techniques developed since Directive 2001/18/EC entered into force are not exempt and products obtained by these techniques need to fulfil all the obligations laid down in Directive 2001/18/EC and Regulation (EC) No 1829/2003.

How will the Commission ensure that this ruling is enforced in a harmonised way throughout the entire Union, including with regard to the traceability and biosecurity obligations laid down in Directive 2001/18/EC on crops and products obtained through these techniques?

Last updated: 30 October 2018Legal notice